Consistent with these studies, we demonstrated that administration of GMI could serve as a therapeutic approach to inhibit IL-6/Stat3 signaling, thereby attenuating cancer stemness, invasiveness and chemo-resistance. The gene discussed is IL6; the disease is cancer.